Last reviewed · How we verify
Prograf capsule 1mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Prograf capsule 1mg (Prograf capsule 1mg) — Chong Kun Dang Pharmaceutical.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prograf capsule 1mg TARGET | Prograf capsule 1mg | Chong Kun Dang Pharmaceutical | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prograf capsule 1mg CI watch — RSS
- Prograf capsule 1mg CI watch — Atom
- Prograf capsule 1mg CI watch — JSON
- Prograf capsule 1mg alone — RSS
Cite this brief
Drug Landscape (2026). Prograf capsule 1mg — Competitive Intelligence Brief. https://druglandscape.com/ci/prograf-capsule-1mg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing